Evidence map›Paper›PMID 33650216›Full record

ArticleActa physiologica (Oxford, England)2021

Zymogen-locked mutant prostasin (Prss8) leads to incomplete proteolytic activation of the epithelial sodium channel (ENaC) and severely compromises triamterene tolerance in mice.

Daniel Essigke, Alexandr V Ilyaskin, Matthias Wörn, Bernhard N Bohnert, Mengyun Xiao, Christoph Daniel, Kerstin Amann, Andreas L Birkenfeld, Roman Szabo, Thomas H Bugge and 2 more

Open access · greenAbstract read
In one paragraph

Article in Acta physiologica (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Impact of aldosterone deficiency on the development of diuretic resistance in mice.Pflugers Archiv : European journal of physiology · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Activation of renal epithelial NaFrontiers in pediatrics · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. ENaC activation by proteases.Acta physiologica (Oxford, England) · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Daniel EssigkeDepartment of Internal Medicine, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tuebingen, Germany.
Alexandr V IlyaskinInstitute of Cellular and Molecular Physiology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Matthias WörnDepartment of Internal Medicine, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tuebingen, Germany.
Bernhard N BohnertDepartment of Internal Medicine, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tuebingen, Germany.ORCID 0000-0003-0169-3948
Mengyun XiaoDepartment of Internal Medicine, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tuebingen, Germany.
Christoph DanielInstitute of Pathology, Department of Nephropathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Kerstin AmannInstitute of Pathology, Department of Nephropathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Andreas L BirkenfeldDepartment of Internal Medicine, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tuebingen, Germany.
Roman SzaboProteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Thomas H BuggeProteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Christoph KorbmacherInstitute of Cellular and Molecular Physiology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Ferruh ArtuncDepartment of Internal Medicine, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tuebingen, Germany.ORCID 0000-0002-3777-9316
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEDeutsches Diabetes-Zentrum e.V. · DENational Institutes of Health · US

Funding

Cell surface serine proteases in development, tissue repair, and malignancyZIADE000699 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI BUGGE, THOMAS H · 2009 to 2025
$34.1M
Serine Proteases In Remodeling Of The Extracellular MatrZ01DE000699 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI BUGGE, THOMAS H · 2000 to 2008
$3.2M
Intramural NIH HHS Z01 DE000699
6 · The paper itself

Abstract

aimThe serine protease prostasin (Prss8) is expressed in the distal tubule and stimulates proteolytic activation of the epithelial sodium channel (ENaC) in co-expression experiments in vitro. The aim of this study was to explore the role of prostasin in proteolytic ENaC activation in the kidney in vivo.

methodsWe used genetically modified knockin mice carrying a Prss8 mutation abolishing proteolytic activity (Prss8-S238A) or a mutation leading to a zymogen-locked state (Prss8-R44Q). Mice were challenged with low sodium diet and diuretics. Regulation of ENaC activity by Prss8-S238A and Prss8-R44Q was studied in vitro using the Xenopus laevis oocyte expression system.

resultsCo-expression of murine ENaC with Prss8-wt or Prss8-S238A in oocytes caused maximal proteolytic ENaC activation, whereas ENaC was activated only partially in oocytes co-expressing Prss8-R44Q. This was paralleled by a reduced proteolytic activity at the cell surface of Prss8-R44Q expressing oocytes. Sodium conservation under low sodium diet was preserved in Prss8-S238A and Prss8-R44Q mice but with higher plasma aldosterone concentrations in Prss8-R44Q mice. Treatment with the ENaC inhibitor triamterene over four days was tolerated in Prss8-wt and Prss8-S238A mice, whereas Prss8-R44Q mice developed salt wasting and severe weight loss associated with hyperkalemia and acidosis consistent with impaired ENaC function and renal failure.

conclusionUnlike proteolytically inactive Prss8-S238A, zymogen-locked Prss8-R44Q produces incomplete proteolytic ENaC activation in vitro and causes a severe renal phenotype in mice treated with the ENaC inhibitor triamterene. This indicates that Prss8 plays a role in proteolytic ENaC activation and renal function independent of its proteolytic activity.

Indexed as

Enzyme PrecursorsEpithelial Sodium ChannelsAnimalsMiceOocytesProstasinSerine EndopeptidasesTriamtereneXenopus laevisEnzyme PrecursorsEpithelial Sodium ChannelsProstasinSerine EndopeptidasesTriamtereneENaCepithelial sodium channelProstasinPrss8Prss8-R44QPrss8-S238A

Identifiers

PMID33650216
PMCPMC8159854
OpenAlexW3134429488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.